Alexandria Real Estate: Quality At A Fair Price

digicomphoto/iStock via Getty Images Dear readers, Alexandria Real Estate Equities (NYSE:ARE) is a blue-chip REIT focused on leasing exclusively to life science tenants in biotech and big pharma. The REIT has generated impressive shareholder returns since going public in 1997 and continues to deliver growth year after year with a 10-year FFO per share CAGR of 7.4%. Last year, the stock price plummeted on fears that life science is not that different from office and may experience occupancy issues. I address ...